|
|
Volumn 28, Issue 8, 2008, Pages 1041-1058
|
|
Key articles and guidelines in the management of hypertension: 2008 Update
a
|
|
Author keywords
blockers; Blood pressure control; Cardiovascular disease; Clinical trials; Hypertension; Key articles; Meta analysis; Treatment guidelines
|
|
Indexed keywords
AMLODIPINE;
ANGIOTENSIN RECEPTOR ANTAGONIST;
ATENOLOL;
BENAZEPRIL;
BETA ADRENERGIC RECEPTOR BLOCKING AGENT;
CALCIUM CHANNEL BLOCKING AGENT;
CANDESARTAN;
CARVEDILOL;
CHLORTALIDONE;
CHOLESTEROL;
DIHYDROPYRIDINE;
DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;
DIURETIC AGENT;
ENALAPRIL;
EPROSARTAN;
FELODIPINE;
HYDROCHLOROTHIAZIDE;
INDAPAMIDE;
LOSARTAN;
METOPROLOL;
METOPROLOL TARTRATE;
NITRENDIPINE;
PERINDOPRIL;
RAMIPRIL;
THIAZIDE DIURETIC AGENT;
TRANDOLAPRIL;
TRIACYLGLYCEROL;
UNINDEXED DRUG;
VALSARTAN;
VERAPAMIL;
ANTIHYPERTENSIVE THERAPY;
BLOOD PRESSURE MEASUREMENT;
BLOOD PRESSURE REGULATION;
CARDIOVASCULAR DISEASE;
CHOLESTEROL BLOOD LEVEL;
CLINICAL TRIAL;
COMBINATION CHEMOTHERAPY;
DIASTOLIC BLOOD PRESSURE;
DISEASE SEVERITY;
DRUG EFFICACY;
DRUG INDICATION;
DRUG TOLERABILITY;
DRUG WITHDRAWAL;
ESSENTIAL HYPERTENSION;
EXERCISE;
HEART INFARCTION;
HIGH RISK PATIENT;
HUMAN;
HYPERTENSION;
INSULIN RESISTANCE;
LIFESTYLE MODIFICATION;
LOW DRUG DOSE;
LOW FAT DIET;
MEAN ARTERIAL PRESSURE;
MEDITATION;
META ANALYSIS;
MONOTHERAPY;
NOTE;
PATIENT CARE;
PATIENT COUNSELING;
PRACTICE GUIDELINE;
PROGNOSIS;
RISK BENEFIT ANALYSIS;
RISK FACTOR;
SELF CARE;
SIDE EFFECT;
STROKE;
SYSTEMATIC REVIEW;
SYSTOLIC BLOOD PRESSURE;
TREATMENT OUTCOME;
TRIACYLGLYCEROL BLOOD LEVEL;
UNSPECIFIED SIDE EFFECT;
WEIGHT GAIN;
HUMANS;
HYPERTENSION;
PRACTICE GUIDELINES AS TOPIC;
|
|
EID: 48249090417
PISSN: 02770008
EISSN: None
Source Type: Journal
DOI: 10.1592/phco.28.8.1041 Document Type: Note |
|
Times cited : (10)
|
|
References (5)
|
